Fifth Third Bancorp Lowers Stock Position in The Cooper Companies, Inc. $COO

Fifth Third Bancorp lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,543 shares of the medical device company’s stock after selling 335 shares during the quarter. Fifth Third Bancorp’s holdings in Cooper Companies were worth $537,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of COO. Wealth Enhancement Advisory Services LLC boosted its stake in Cooper Companies by 3.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 9,370 shares of the medical device company’s stock worth $861,000 after buying an additional 309 shares during the period. Wellington Management Group LLP boosted its stake in shares of Cooper Companies by 517.1% in the fourth quarter. Wellington Management Group LLP now owns 175,152 shares of the medical device company’s stock valued at $16,102,000 after purchasing an additional 146,771 shares during the period. GAMMA Investing LLC boosted its stake in shares of Cooper Companies by 5,733.1% in the first quarter. GAMMA Investing LLC now owns 210,285 shares of the medical device company’s stock valued at $17,738,000 after purchasing an additional 206,680 shares during the period. Rhumbline Advisers boosted its stake in shares of Cooper Companies by 9.6% in the first quarter. Rhumbline Advisers now owns 388,960 shares of the medical device company’s stock valued at $32,809,000 after purchasing an additional 34,060 shares during the period. Finally, Czech National Bank boosted its stake in shares of Cooper Companies by 6.2% in the first quarter. Czech National Bank now owns 45,841 shares of the medical device company’s stock valued at $3,867,000 after purchasing an additional 2,660 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 0.2%

NASDAQ COO opened at $67.67 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $110.68. The company has a 50-day moving average of $70.06 and a 200-day moving average of $74.38. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The company has a market cap of $13.45 billion, a P/E ratio of 33.34, a P/E/G ratio of 1.77 and a beta of 0.97.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the prior year, the company posted $0.96 EPS. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has initiated a share buyback program on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to buy up to 15.4% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III bought 10,000 shares of the firm’s stock in a transaction dated Friday, September 5th. The stock was acquired at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the acquisition, the chief executive officer owned 226,151 shares of the company’s stock, valued at $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Daniel G. Mcbride bought 3,000 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, with a total value of $195,120.00. Following the acquisition, the chief operating officer directly owned 63,120 shares in the company, valued at approximately $4,105,324.80. This trade represents a 4.99% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 17,975 shares of company stock worth $1,216,346. Company insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on COO shares. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Cooper Companies in a report on Thursday, August 28th. BNP Paribas raised shares of Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. BNP Paribas Exane raised shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price objective on the stock in a report on Tuesday, July 22nd. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, August 28th. Finally, Loop Capital set a $100.00 target price on shares of Cooper Companies in a research report on Tuesday, June 17th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.64.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.